Pulmonary CancerNCT05915221
Effect of SMS Use on Postoperative Respiratory and Cough Exercise Compliance
A study testing SMS in people with Pulmonary Cancer and Surgery, run by Trakya University at 2 sites in Turkey (Türkiye).
Trial summary
Aim: This randomized controlled trial study aimed to evaluate the effect of SMS use on compliance with postoperative breathing and coughing exercises and patient satisfaction in patients undergoing pulmonary lobectomy for lung cancer surgery. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Pulmonary Cancer, Surgery
- What is being tested?
- SMS
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 62 participants
- Where
- 2 sitesTurkey (Türkiye)
- Study dates
- 1 Feb 2022to 3 Apr 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- undergoing elective pulmonary lobectomy,
- having preoperative normal lung capacity (pulmonary function test result FEV1/FVC >70%),
- being compatible with the use of triflow, undergoing pulmonary lobectomy for the first time,
- volunteering to participate in the study,
- having mental competence,
- not having Turkish communication problems,
- having a personal mobile phone and accepting to send SMS,
- being an adult (≥18)
Who cannot join
- If any SMSs are not received during the study period, the patient will be excluded from the study.
Trial locations and contacts
2 sites in 1 country.
Turkey (Türkiye)2 sites
Trakya University
Edirne, 22030
Turkey, Trakya University
Edirne, 22030
About this study
Official title: Effect of SMS Reminder Use on Postoperative Respiratory and Cough Exercise Compliance of Patients After Lung Cancer Surgery
Aim: This randomized controlled trial study aimed to evaluate the effect of SMS use on compliance with postoperative breathing and coughing exercises and patient satisfaction in patients undergoing pulmonary lobectomy for lung cancer surgery.
Material and methods: In the study, 62 patients who underwent lobectomy in a university hospital's thoracic surgery clinic between 01.02.2022 and 03.04.2023. The intervention group was chosen to be the group that received SMS messages.
Read the detailed description
Background: Patients undergoing lung resection should be encouraged to cough, take deep breaths for pulmonary rehabilitation within the scope of enhanced recovery after surgery protocols. The success of protocols is related to patient compliance. SMS-based interventions increase compliance with medications and protocols in surgical patients and reduce hospital readmission rates, while improving patients' clinical participation and satisfaction.
Aim: This randomized controlled trial study aimed to evaluate the effect of SMS use on compliance with postoperative breathing and coughing exercises and patient satisfaction in patients undergoing pulmonary lobectomy for lung cancer surgery.
Material and methods: In the study, 62 patients who underwent lobectomy in a university hospital's thoracic surgery clinic between 01.02.2022 and 03.04.2023. The intervention group was chosen to be the group that received SMS messages.
"The Information Form", "Postoperative exercise follow-up chart", "Postoperative patient evaluation form" and "Patient satisfaction form were used in data collection. Independent sample t-test, Pearson chi- square and Mann Whitney U test were conducted for statistical analyses.
- Conditions
- Pulmonary Cancer, Surgery
- Being tested
- SMS
- Keywords
- short message service, breathing and coughing exercises, pulmonary lobectomy
- Medical subject headings
- Lung Neoplasms, Respiratory Aspiration
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
SMSProcedure or surgery
Receive SMS
| Study group | Role | What they receive |
|---|---|---|
| Control group | No intervention | The control group was chosen to be the group that did not receive SMS. |
| SMS group | Experimental | The intervention group was chosen to be the group that received SMS messages. Receives: Procedure: SMS |
What is being measured
The primary outcome is the main question the study is designed to answer.
primary outcome measure
The primary point of the study was defined as evaluating the effect of sending SMSs, on compliance with postoperative breathing and coughing exercises undergoing pulmonary lobectomy surgery.A postoperative exercise follow-up chart includes the breathing, coughing, triflow exercises performed by the patients on the 1st and 4th postoperative days and the hours of the exercises. The mean number of breathing and coughing exercises on the first and fourth postoperative days was recorded.
Measured: change from after implamentation 1st and 4rd days of operation.
Secondary outcomes (1)
secondary outcome measure
The second point of the study was defined as evaluating the effect of sending SMSs, on patient satisfaction undergoing pulmonary lobectomy surgery. "Patient satisfaction form" were used for data collection.The patient satisfaction form" consisted of two questions. The first question questioned the satisfaction with SMS reminders. Satisfaction levels were categorized in 4 ways. Level of "very satisfied" and "satisfied" were accepted as high satisfaction level, "was not satisfied" and "was not satisfied at all" were accepted as low level.
Measured: change from after implamentation 4rd days of operation.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 Jun 2023
- Study start1 Feb 2022
- Primary completion3 Apr 2023
- Study completion3 Apr 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Pulmonary CancerStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- The group that received SMS was selected as the intervention group. Patients in the control group did not receive any SMS within the scope of the study
- Masking
- None (open label)
- Enrolment
- 62 participants (actual)
Sponsor and investigators
- Lead sponsor
- Trakya University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Zeynep Kızılcık Ozkan, Trakya University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05915221
- Sponsor's protocol ID
- 2021/526
- Status last verified
- Jun 2023
- First submitted
- 2 Jun 2023
- Last updated
- 22 Jun 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 22 Jun 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effect of SMS Reminder Use on Postoperative Respiratory and Cough Exercise Compliance of Patients After Lung Cancer Surgery
- ClinicalTrials.gov ID
- NCT05915221
- Acronym / sponsor ID
- 2021/526
- Conditions
- Pulmonary Cancer, Surgery
- Keywords
- short message service, breathing and coughing exercises, pulmonary lobectomy
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 62 participants (actual)
- Lead sponsor
- Trakya UniversityUniversity, hospital or other
- Study start
- 1 Feb 2022 (actual)
- Primary completion
- 3 Apr 2023 (actual)
- Study completion
- 3 Apr 2023 (actual)
- First posted
- 22 Jun 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Aim: This randomized controlled trial study aimed to evaluate the effect of SMS use on compliance with postoperative breathing and coughing exercises and patient satisfaction in patients undergoing pulmonary lobectomy for lung cancer surgery.
Material and methods: In the study, 62 patients who underwent lobectomy in a university hospital's thoracic surgery clinic between 01.02.2022 and 03.04.2023. The intervention group was chosen to be the group that received SMS messages.
Detailed description
Background: Patients undergoing lung resection should be encouraged to cough, take deep breaths for pulmonary rehabilitation within the scope of enhanced recovery after surgery protocols. The success of protocols is related to patient compliance. SMS-based interventions increase compliance with medications and protocols in surgical patients and reduce hospital readmission rates, while improving patients' clinical participation and satisfaction.
Aim: This randomized controlled trial study aimed to evaluate the effect of SMS use on compliance with postoperative breathing and coughing exercises and patient satisfaction in patients undergoing pulmonary lobectomy for lung cancer surgery.
Material and methods: In the study, 62 patients who underwent lobectomy in a university hospital's thoracic surgery clinic between 01.02.2022 and 03.04.2023. The intervention group was chosen to be the group that received SMS messages.
"The Information Form", "Postoperative exercise follow-up chart", "Postoperative patient evaluation form" and "Patient satisfaction form were used in data collection. Independent sample t-test, Pearson chi- square and Mann Whitney U test were conducted for statistical analyses.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- The group that received SMS was selected as the intervention group. Patients in the control group did not receive any SMS within the scope of the study
| Arm | Type | Receives |
|---|---|---|
| Control group | No intervention | –The control group was chosen to be the group that did not receive SMS. |
| SMS group | Experimental | Procedure: SMSThe intervention group was chosen to be the group that received SMS messages. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (8 listed)
- undergoing elective pulmonary lobectomy,
- having preoperative normal lung capacity (pulmonary function test result FEV1/FVC >70%),
- being compatible with the use of triflow, undergoing pulmonary lobectomy for the first time,
- volunteering to participate in the study,
- having mental competence,
Key exclusion criteria (1 listed)
- If any SMSs are not received during the study period, the patient will be excluded from the study.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| SMSReceive SMS | Procedure or surgery | SMS group |
Primary outcome
primary outcome measure
Time frame: change from after implamentation 1st and 4rd days of operation.
The primary point of the study was defined as evaluating the effect of sending SMSs, on compliance with postoperative breathing and coughing exercises undergoing pulmonary lobectomy surgery.A postoperative exercise follow-up chart includes the breathing, coughing, triflow exercises performed by the patients on the 1st and 4th postoperative days and the hours of the exercises. The mean number of breathing and coughing exercises on the first and fourth postoperative days was recorded.
1 secondary outcome
secondary outcome measure
Time frame: change from after implamentation 4rd days of operation.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 22 Jun 2023.
- Individual participant dataSharing planned: No
Related trials for Pulmonary Cancer
RecruitingPhase 1/2
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Solid Tumor, Non-Small Cell Lung Cancer
RecruitingObservational study
A Prospective ,Multicenter ,Non-interventional ,Real-world Study Observing Changes in Molecular Markers Osimertinib Targeted Therapy in EGFRm NSCLC
Non Small Cell Lung Cancer
Active, not recruiting
Streamlined Geriatric and Oncological Evaluation Based On IC Technology
Breast Cancer, Comorbidities and Coexisting Conditions
RecruitingPhase 3
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Non-Small Cell Lung Cancer (NSCLC)
Active, not recruitingPhase 2
Datopotamab Deruxtecan (Dato-DXd, DS-1062a) in Advanced and/or Unresectable Non-Small Cell Lung Cancer
Metastatic Lung Cancer, Advanced Non Small Cell Lung Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing SMS in people with Pulmonary Cancer and Surgery, run by Trakya University at 2 sites in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 8 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 22 Jun 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
primary outcome measure (time frame: change from after implamentation 1st and 4rd days of operation.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Jun 2023.